Header graphic for print
Focus on Regulation

Tag Archives: Poland

Effects of Brexit on reimbursement decisions concerning medicinal products in Poland

The President of the Office for the Registration of Medicinal Products, Medical Devices, and Biocidal Products (URPL) estimates that approximately 20% of all the 10,000 medicinal products registered in Poland will be affected by the effects of Brexit. Out of this number, according to media reports, new reimbursement decisions will need to be issued for

Overhaul of Polish consumer law

Important amendments to Polish consumer protection law have been introduced which increase the risk of doing business in Poland. Please see our e-alert summarising the principal changes.